Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Series B

Goldfinch Bio holds on to $100m
Existing backer Gilead Sciences returned for a series B round that boosted the kidney disease therapy developer's total funding to $160m.
Enko Chem reaps $45m series B
Rabobank was among the investors as the crop protection technology developer publicly launched having raised a total of $66m since inception.
AIpark aces series C round
The smart parking technology developer has received $42.4m of fresh capital which came two years after a series B round led by Nio Capital.
SevenRooms books in $50m
The hospitality data software provider received series B cash from Providence Strategic Growth to add to earlier funding from backers including Comcast and Amazon.
Corporate venturing deal net: 22-26 June 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
SQream scares up series B-plus cash
Alibaba and Sistema VC returned for a $39.4m round that took the total raised by the data analysis platform developer to more than $76m.
Nylas connects to corporates in $25m round
Citi Ventures and existing backer Slack Fund helped the communications API provider take its overall funding to more than $55m.
Big Health to grow with $39m
Kaiser Permanente Ventures and Samsung Next invested in the digital mental health treatment developer through a series B round that will fund product development and commercialisation.

Other News

Kaia takes care of $26m series B
Optum Ventures co-led a series B round that took the chronic disease management platform's total funding to $50m.
Uptycs sticks series B with $30m
Returning investor Comcast Ventures contributed to a round that pushed the total raised by the security management software developer to $43m.
Corporate venturing deal net: 15-19 June 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Abacus Insights slides in $35m
The healthcare data integrator boosted its overall funding to $53m in a series B round led by Blue Venture Fund that included Echo Health Ventures.
EtheRNA extracts series B funding
Grand Decade and existing investor Boehringer Ingelheim Venture Fund helped supply $38.2m for the mRNA immunotherapy developer and Vrije Universiteit Brussel spinout.
C4 Therapeutics seals $170m round
The Roche, Novartis and Kraft Group-backed, protein degradation-focused drug developer received $150m in series B funding and $20m in venture debt.

Editor's Picks

Intel spreads $72m across 12 companies
Intel Capital has revealed investments in 12 US or China-based portfolio companies and a partnership with the NBA.
Big Deal: Joby completes $100m funding job
Joby Aviation has raised $100m in an Intel Capital-led series B round that included JetBlue Technology Ventures, indicating the rise in air-based corporate venturing.
Huochebang loads up another $156m
Baidu Capital, which has just appointed a CEO, has co-led the logistics platform's series B-2 round, adding to a $115m tranche co-led by Tencent in December.
Big Deal: Corporates find Unity
Unity Biotechnology, which raised $116m last week, is the fourth Arch Venture Partners-launched startup to be backed by WuXi PharmaTech.
test reg